Mothercare PLC Mothercare Plc : Holding(s) In Company

 
TIDMMTC 
 
 
 
 
For filings with the FSA include the annex 
For filings with issuer exclude the annex 
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
 
1. Identity of the issuer or the underlying issuer                                       Mothercare Plc 
 of existing shares to which voting rights are 
 attached: (ii) 
2 Reason for the notification (please tick the appropriate 
 box or boxes): 
An acquisition or disposal of voting rights                                          X 
An acquisition or disposal of qualifying financial 
 instruments which may result in the acquisition of 
 shares already issued to which voting rights are attached 
An acquisition or disposal of instruments with similar 
 economic effect to qualifying financial instruments 
An event changing the breakdown of voting rights 
Other (please specify): 
3. Full name of person(s) subject to the                               Richard Griffiths and controlled 
 notification obligation: (iii)                                                            undertakings 
4. Full name of shareholder(s) 
 (if different from 3.):(iv) 
5. Date of the transaction and date on                                                    17 March 2017 
 which the threshold is crossed or 
 reached: (v) 
6. Date on which issuer notified:                                                         21 March 2017 
7. Threshold(s) that is/are crossed or                                                           > 3,4% 
 reached: (vi, vii) 
 
 
 
 
8. Notified details: 
A: Voting rights attached to shares (viii, ix) 
Class/type of 
 shares             Situation previous 
 if possible using   to the triggering 
 the ISIN CODE       transaction                        Resulting situation after the triggering transaction 
                                      Number 
                    Number             of 
                    of                 Voting           Number                        Number of voting 
                    Shares             Rights            of shares                     rights                                           % of voting rights (x) 
                                                        Direct                        Direct (xi)           Indirect (xii)              Direct             Indirect 
 
  Ordinary 
  GB0009067447      < 3%              < 3%              1,214,271                     1,214,271                                         0.71% 
 
 
B: Qualifying Financial Instruments 
Resulting situation after the triggering transaction 
                                                                                        Number of voting 
                                                                                         rights that may be 
                                                                                         acquired if the 
Type of financial       Expiration      Exercise/                                        instrument is                                      % of voting 
 instrument              date (xiii)     Conversion Period (xiv)                         exercised/ converted.                               rights 
CFD                                                                                     6,164,719                                           3.61% 
 
C: Financial Instruments with similar economic effect 
 to Qualifying Financial Instruments (xv, xvi) 
Resulting situation after the triggering transaction 
Type of financial                     Expiration      Exercise/ Conversion 
 instrument           Exercise price  date (xvii)     period (xviii)                  Number of voting rights instrument refers to        % of voting rights (xix, xx) 
                                                                                                                                          Nominal            Delta 
 
 
Total (A+B+C) 
Number of voting rights                                   Percentage of voting rights 
7,378,990                                                 4.32% 
 
   9. Chain of controlled undertakings through which the voting rights 
and/or the 
 
   financial instruments are effectively held, if applicable: (xxi) 
 
 
 
 
 
 
Seren Investment Management Limited   1,178,271 
Oak Trust Limited                        36,000 
                                      1,214,271 
QFI's 
CFD - Richard Griffiths               6,164,719 
Total                                 7,378,990 
 
 
   The above entities are controlled by Richard Griffiths 
 
   Proxy Voting: 
 
   10. Name of the proxy holder: 
 
   11. Number of voting rights proxy holder will cease 
 
   to hold: 
 
   12. Date on which proxy holder will cease to hold 
 
   voting rights: 
 
   13. Additional information: 
 
   14. Contact name: 
 
   James Sutcliffe 
 
   15. Contact telephone number: 
 
   [phone] 
 
 
 
 
Note: Annex should only be submitted to the FSA not 
 the issuer 
Annex: Notification of major interests in shares(xxii) 
 
A: Identity of the persons or legal entity subject 
 to the notification obligation 
Full name 
 (including legal form of legal entities) 
Contact address 
 (registered office for legal entities) 
Phone number & email 
Other useful information 
 (at least legal representative for legal persons) 
 
B: Identity of the notifier, if applicable 
Full name 
Contact address 
Phone number & email 
Other useful information 
 (e.g. functional relationship with the person or legal 
 entity subject to the notification obligation) 
 
C: Additional information 
 
For notes on how to complete form TR-1 please see 
 the FSA website. 
 
 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Mothercare Plc via Globenewswire 
 
 
  http://www.mothercare.com 
 

(END) Dow Jones Newswires

March 21, 2017 05:57 ET (09:57 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.